These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15333195)

  • 41. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urine color test to monitor isoniazid compliance: "pissin' in the wind"?
    Hollender ES; Ashkin D; Narita M
    Chest; 2003 Mar; 123(3):668-70. PubMed ID: 12628857
    [No Abstract]   [Full Text] [Related]  

  • 44. Urine color testing and isoniazid monitoring.
    Cope GF; Whitfield R
    Chest; 2003 Dec; 124(6):2405; author reply 2405. PubMed ID: 14665533
    [No Abstract]   [Full Text] [Related]  

  • 45. SPECIFICITY OF THE ISONIAZID DROP TEST FOR CONTROL OF DOMICILIARY TREATMENT OF TUBERCULOSIS.
    HAMILTON EJ; JESSAMINE AG; EIDUS L
    Can Med Assoc J; 1964 Mar; 90(11):695-7. PubMed ID: 14127386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of isoniazid as a marker to monitor the self-administration of medicaments.
    Stark JE; Ellard GA; Gammon PT; Fox W
    Br J Clin Pharmacol; 1975 Aug; 2(4):355-8. PubMed ID: 788733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the Belles-Littleman filter paper spot test. Tuberculosis prevention trial, Bangalore, South India.
    Am Rev Respir Dis; 1967 Jul; 96(1):17-27. PubMed ID: 6029114
    [No Abstract]   [Full Text] [Related]  

  • 48. Biomarker-confirmed suboptimal adherence to isoniazid preventive therapy among children with HIV in western Kenya.
    Onyango DO; van der Sande MAB; Yuen CM; Were J; Mecha J; Njagi LN; Panpradist N; Matemo D; Leon D; Lutz B; Kinuthia J; John-Stewart G; Lacourse SM
    AIDS; 2024 Jan; 38(1):39-47. PubMed ID: 37773037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alternative Methods for Therapeutic Drug Monitoring and Dose Adjustment of Tuberculosis Treatment in Clinical Settings: A Systematic Review.
    Rao PS; Modi N; Nguyen NT; Vu DH; Xie YL; Gandhi M; Gerona R; Metcalfe J; Heysell SK; Alffenaar JC
    Clin Pharmacokinet; 2023 Mar; 62(3):375-398. PubMed ID: 36869170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial.
    Burman M; Copas A; Zenner D; Hickson V; Gosce L; Trathen D; Ashcroft R; Martineau AR; Abubakar I; Griffiths C; Kunst H
    BMC Public Health; 2019 Nov; 19(1):1598. PubMed ID: 31783742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities.
    Subbaraman R; de Mondesert L; Musiimenta A; Pai M; Mayer KH; Thomas BE; Haberer J
    BMJ Glob Health; 2018; 3(5):e001018. PubMed ID: 30364330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isoniazid preventive treatment among child contacts of adults with smear-positive tuberculosis in The Gambia.
    Egere U; Sillah A; Togun T; Kandeh S; Cole F; Jallow A; Able-Thomas A; Hoelscher M; Heinrich N; Hill PC; Kampmann B
    Public Health Action; 2016 Dec; 6(4):226-231. PubMed ID: 28123958
    [No Abstract]   [Full Text] [Related]  

  • 53. Point-of-care urine tests for smoking status and isoniazid treatment monitoring in adult patients.
    Nicolau I; Tian L; Menzies D; Ostiguy G; Pai M
    PLoS One; 2012; 7(9):e45913. PubMed ID: 23029310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study.
    van den Boogaard J; Lyimo RA; Boeree MJ; Kibiki GS; Aarnoutse RE
    Bull World Health Organ; 2011 Sep; 89(9):632-9. PubMed ID: 21897483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The reliability and practicality of the Arkansas method assay of isoniazid adherence.
    Schmitz KE; Hovell MF; Wong CA; Kelley NJ; Nilsen D; Blumberg EJ; Hill LL; Sipan CL; Kolody B; Chatfield DA
    Clin Nurs Res; 2010 May; 19(2):131-43. PubMed ID: 20435784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.
    Guerra RL; Conde MB; Efron A; Loredo C; Bastos G; Chaisson RE; Golub JE
    Respir Med; 2010 May; 104(5):754-7. PubMed ID: 20202806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Point-of-care test to monitor adherence to anti-tuberculous treatment.
    Whitfield R; Cope GF
    Ann Clin Biochem; 2004 Sep; 41(Pt 5):411-3. PubMed ID: 15333195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The value of urine testing for verifying adherence to anti-tuberculosis chemotherapy in children and adults in Uganda.
    Meissner PE; Musoke P; Okwera A; Bunn JE; Coulter JB
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):903-8. PubMed ID: 12365577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Follow-up of compliance with tuberculosis treatment in children: monitoring by urine tests.
    Palanduz A; Gultekin D; Kayaalp N
    Pediatr Pulmonol; 2003 Jul; 36(1):55-7. PubMed ID: 12772224
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.